GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Gross Margin %

Allurion Technologies (Allurion Technologies) Gross Margin % : 78.08% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Allurion Technologies's Gross Profit for the three months ended in Dec. 2023 was $6.43 Mil. Allurion Technologies's Revenue for the three months ended in Dec. 2023 was $8.24 Mil. Therefore, Allurion Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 78.08%.


The historical rank and industry rank for Allurion Technologies's Gross Margin % or its related term are showing as below:

ALUR' s Gross Margin % Range Over the Past 10 Years
Min: 76.33   Med: 77.61   Max: 79
Current: 77.61


During the past 3 years, the highest Gross Margin % of Allurion Technologies was 79.00%. The lowest was 76.33%. And the median was 77.61%.

ALUR's Gross Margin % is ranked better than
87.44% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs ALUR: 77.61

Allurion Technologies had a gross margin of 78.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Allurion Technologies was 0.00% per year.


Allurion Technologies Gross Margin % Historical Data

The historical data trend for Allurion Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Gross Margin % Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23
Gross Margin %
76.33 79.00 77.61

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only 79.46 79.11 76.91 76.75 78.08

Competitive Comparison of Allurion Technologies's Gross Margin %

For the Medical Devices subindustry, Allurion Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Gross Margin % falls into.



Allurion Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Allurion Technologies's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=41.5 / 53.467
=(Revenue - Cost of Goods Sold) / Revenue
=(53.467 - 11.97) / 53.467
=77.61 %

Allurion Technologies's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=6.4 / 8.235
=(Revenue - Cost of Goods Sold) / Revenue
=(8.235 - 1.805) / 8.235
=78.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Allurion Technologies  (NYSE:ALUR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Allurion Technologies had a gross margin of 78.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Allurion Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies (Allurion Technologies) Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Website
Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760